News

Why Is Aclarion (ACON) Stock Down 19% Today?

Aclarion (NASDAQ: ACON ) stock is falling on Monday after the healthcare technology company revealed plans for a public offering of its shares. Aclarion intends to offer up to 3,888,888 units in this offering.

02/26/2024

Why Is Aclarion (ACON) Stock Down 16% Today?

Aclarion (NASDAQ: ACON ) stock is falling on Monday after the healthcare technology company announced additional exchange agreements with accredited investors. According to a filing with the Securities and Exchange Commission (SEC), Aclarion issued 500,000 shares of ACON stock in exchange for $1,185,226 of principal and accrued interest on unsecured non-convertible notes.

01/29/2024

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Aclarion, Inc. (ACON) a buy, sell, or hold?

Aclarion, Inc. (ACON) can sell. Click on Rating Page for detail.

What is Aclarion, Inc.'s stock price?

The price of Aclarion, Inc. (ACON) is 0.3298 and it was updated on 2024-04-29 09:00:36.

Is Aclarion, Inc. (ACON) overvalued or undervalued?

Currently Aclarion, Inc. (ACON) is in undervalued.

News

From:

To:

News
10 Top Penny Stocks To Watch Under $1 Penny stocks under $1 to watch this week. The post 10 Top Penny Stocks To Watch Under $1 appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. Tue, Apr. 25, 2023
Aclarion skyrockets on positive trial data for lower back pain intelligence platform Aclarion shares skyrocketed after the company published data from a two-year trial that demonstrated improved surgical outcomes for discogenic lower back pain (DLBP) surgeries at chemically painful lumbar discs identified by Nociscan, the company's intelligence platform for measuring pain biomarkers in the lumbar spine. Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine and uses its proprietary signal processing techniques to extract and quantify chemical biomarkers associated with disc pain, according to Aclarion. Mon, Apr. 24, 2023
Penny Stocks to Buy Now? 7 Under $1 To Watch This Week Penny stocks to watch under $1 this week. The post Penny Stocks to Buy Now? Mon, Apr. 24, 2023
Aclarion to Present at the Jan 26th Virtual Investor Summit Microcap Event Broomfield, Colorado--(Newsfile Corp. - January 17, 2023) - Aclarion, Inc., (NASDAQ: ACON) (NASDAQ: ACONW) ("Aclarion" or the "Company"), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that it will be presenting virtually at the upcoming Virtual Investor Summit on January 26th.Event: Q1 Investor SummitDate: January 26th, 2023Presentation: January 26th at 12:30 pm ET timeLocation: https://us06web.zoom.us/webinar/register/WN_IyxNcENWRd-KCIMWYg6F6w Tue, Jan. 17, 2023
3 Low Float Penny Stocks To Watch After KSPN Stock Explodes 180% Low float penny stocks to watch right now. The post 3 Low Float Penny Stocks To Watch After KSPN Stock Explodes 180% appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. Wed, Aug. 03, 2022

SEC Filings

SEC Filings
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 04/29/2024
Aclarion, Inc. (ACON) - 497K SEC Filings 04/24/2024
Aclarion, Inc. (ACON) - 497 SEC Filings 04/24/2024
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 04/12/2024
Aclarion, Inc. (ACON) - SC 13G/A SEC Filings 03/29/2024
Aclarion, Inc. (ACON) - 10-K - Current report SEC Filings 03/28/2024
Aclarion, Inc. (ACON) - SC 13G SEC Filings 03/06/2024
Aclarion, Inc. (ACON) - EFFECT SEC Filings 02/27/2024
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 02/27/2024
Aclarion, Inc. (ACON) - 497 SEC Filings 02/27/2024
Aclarion, Inc. (ACON) - 424B4 SEC Filings 02/27/2024
Aclarion, Inc. (ACON) - NPORT-P SEC Filings 02/26/2024
Aclarion, Inc. (ACON) - S-1/A SEC Filings 02/23/2024
Aclarion, Inc. (ACON) - S-1/A SEC Filings 02/21/2024
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 02/21/2024
Aclarion, Inc. (ACON) - S-1/A SEC Filings 02/06/2024
Aclarion, Inc. (ACON) - EFFECT SEC Filings 02/02/2024
Aclarion, Inc. (ACON) - 424B3 SEC Filings 02/01/2024
Aclarion, Inc. (ACON) - S-1/A SEC Filings 01/31/2024
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 01/29/2024
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 01/23/2024
Aclarion, Inc. (ACON) - S-1 SEC Filings 01/22/2024
Aclarion, Inc. (ACON) - SC 13G SEC Filings 01/12/2024
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 01/04/2024
Aclarion, Inc. (ACON) - 424B3 SEC Filings 01/04/2024
Aclarion, Inc. (ACON) - SC 13G/A SEC Filings 12/29/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 12/19/2023
Aclarion, Inc. (ACON) - S-1 SEC Filings 12/11/2023
Aclarion, Inc. (ACON) - N-CSRS SEC Filings 11/29/2023
Aclarion, Inc. (ACON) - NPORT-P SEC Filings 11/27/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 11/22/2023
Aclarion, Inc. (ACON) - 424B3 SEC Filings 11/16/2023
Aclarion, Inc. (ACON) - 10-Q - Quarterly Report SEC Filings 11/14/2023
Aclarion, Inc. (ACON) - DEF 14A SEC Filings 11/13/2023
Aclarion, Inc. (ACON) - PRE 14A SEC Filings 11/01/2023
Aclarion, Inc. (ACON) - SC 13G SEC Filings 10/30/2023
Aclarion, Inc. (ACON) - EFFECT SEC Filings 10/23/2023
Aclarion, Inc. (ACON) - 424B3 SEC Filings 10/23/2023
Aclarion, Inc. (ACON) - S-1/A SEC Filings 10/20/2023
Aclarion, Inc. (ACON) - S-1 SEC Filings 10/10/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 10/10/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 09/28/2023
Aclarion, Inc. (ACON) - 497K SEC Filings 09/11/2023
Aclarion, Inc. (ACON) - 497 SEC Filings 09/11/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 09/07/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 09/01/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 08/31/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 08/25/2023
Aclarion, Inc. (ACON) - 10-Q - Quarterly Report SEC Filings 08/25/2023
Aclarion, Inc. (ACON) - NPORT-P SEC Filings 08/24/2023
Aclarion, Inc. (ACON) - N-PX SEC Filings 08/24/2023
Aclarion, Inc. (ACON) - NT 10-Q - Quarterly Report SEC Filings 08/14/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 08/14/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 08/10/2023
Aclarion, Inc. (ACON) - 497J SEC Filings 08/01/2023
Aclarion, Inc. (ACON) - 497K SEC Filings 07/26/2023
Aclarion, Inc. (ACON) - 485BPOS SEC Filings 07/26/2023
Aclarion, Inc. (ACON) - 40-17G SEC Filings 07/21/2023
Aclarion, Inc. (ACON) - EFFECT SEC Filings 07/17/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 07/14/2023
Aclarion, Inc. (ACON) - 424B3 SEC Filings 07/14/2023
Aclarion, Inc. (ACON) - S-1/A SEC Filings 07/12/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 07/07/2023
Aclarion, Inc. (ACON) - S-1 SEC Filings 07/03/2023
Aclarion, Inc. (ACON) - 10-Q - Quarterly Report SEC Filings 07/03/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 06/20/2023
Aclarion, Inc. (ACON) - 24F-2NT SEC Filings 06/20/2023
Aclarion, Inc. (ACON) - N-CEN SEC Filings 06/12/2023
Aclarion, Inc. (ACON) - 10-K/A - Current report SEC Filings 06/12/2023
Aclarion, Inc. (ACON) - D SEC Filings 05/31/2023
Aclarion, Inc. (ACON) - N-CSR SEC Filings 05/30/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 05/30/2023
Aclarion, Inc. (ACON) - NPORT-P SEC Filings 05/25/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 05/23/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 05/17/2023
Aclarion, Inc. (ACON) - NT 10-Q - Quarterly Report SEC Filings 05/16/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 05/16/2023
Aclarion, Inc. (ACON) - 8-K/A - Current report SEC Filings 05/15/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 04/25/2023
Aclarion, Inc. (ACON) - 497 SEC Filings 04/03/2023
Aclarion, Inc. (ACON) - 497 SEC Filings 03/31/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 03/28/2023
Aclarion, Inc. (ACON) - 4 SEC Filings 03/28/2023
Aclarion, Inc. (ACON) - 497 SEC Filings 03/17/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 03/09/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 03/07/2023
Aclarion, Inc. (ACON) - 497 SEC Filings 02/28/2023
Aclarion, Inc. (ACON) - DEF 14A SEC Filings 02/27/2023
Aclarion, Inc. (ACON) - 10-K - Current report SEC Filings 02/27/2023
Aclarion, Inc. (ACON) - NPORT-P SEC Filings 02/24/2023
Aclarion, Inc. (ACON) - 4 SEC Filings 02/21/2023
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 02/17/2023
Aclarion, Inc. (ACON) - PRE 14A SEC Filings 02/14/2023
Aclarion, Inc. (ACON) - SC 13G SEC Filings 02/03/2023
Aclarion, Inc. (ACON) - 4 SEC Filings 12/29/2022
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 12/23/2022
Aclarion, Inc. (ACON) - 4/A SEC Filings 12/08/2022
Aclarion, Inc. (ACON) - 4 SEC Filings 12/06/2022
Aclarion, Inc. (ACON) - N-CSRS SEC Filings 11/29/2022
Aclarion, Inc. (ACON) - NPORT-P SEC Filings 11/25/2022
Aclarion, Inc. (ACON) - 10-Q - Quarterly Report SEC Filings 11/14/2022
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 10/25/2022
Aclarion, Inc. (ACON) - 10-Q - Quarterly Report SEC Filings 08/15/2022
Aclarion, Inc. (ACON) - 10-Q - Quarterly Report SEC Filings 06/06/2022
Aclarion, Inc. (ACON) - S-8 SEC Filings 05/26/2022
Aclarion, Inc. (ACON) - 3/A SEC Filings 05/23/2022
Aclarion, Inc. (ACON) - 3/A SEC Filings 05/19/2022
Aclarion, Inc. (ACON) - 8-K - Current report SEC Filings 04/27/2022
Aclarion, Inc. (ACON) - 424B4 SEC Filings 04/25/2022
Aclarion, Inc. (ACON) - 4 SEC Filings 04/25/2022
Aclarion, Inc. (ACON) - 3/A SEC Filings 04/25/2022
Aclarion, Inc. (ACON) - EFFECT SEC Filings 04/22/2022
Aclarion, Inc. (ACON) - EFFECT SEC Filings 04/22/2022
Aclarion, Inc. (ACON) - 4 SEC Filings 04/22/2022
Aclarion, Inc. (ACON) - 3 SEC Filings 04/22/2022
Aclarion, Inc. (ACON) - CERT SEC Filings 04/21/2022
Aclarion, Inc. (ACON) - 3 SEC Filings 04/21/2022
Aclarion, Inc. (ACON) - S-1/A SEC Filings 04/20/2022
Aclarion, Inc. (ACON) - CORRESP SEC Filings 04/20/2022
Aclarion, Inc. (ACON) - 8-A12B SEC Filings 04/20/2022
Aclarion, Inc. (ACON) - S-1/A SEC Filings 04/19/2022
Aclarion, Inc. (ACON) - S-1/A SEC Filings 04/01/2022
Aclarion, Inc. (ACON) - CORRESP SEC Filings 04/01/2022
Aclarion, Inc. (ACON) - S-1/A SEC Filings 03/23/2022
Aclarion, Inc. (ACON) - CORRESP SEC Filings 03/23/2022
Aclarion, Inc. (ACON) - UPLOAD SEC Filings 03/15/2022
Aclarion, Inc. (ACON) - S-1/A SEC Filings 03/04/2022
Aclarion, Inc. (ACON) - CORRESP SEC Filings 03/04/2022
Aclarion, Inc. (ACON) - UPLOAD SEC Filings 01/26/2022
Aclarion, Inc. (ACON) - S-1 SEC Filings 01/06/2022
Aclarion, Inc. (ACON) - CORRESP SEC Filings 01/05/2022
Aclarion, Inc. (ACON) - UPLOAD SEC Filings 11/30/2021
Aclarion, Inc. (ACON) - D SEC Filings 10/26/2021
Aclarion, Inc. (ACON) - DRS SEC Filings 10/25/2021
Aclarion, Inc. (ACON) - D SEC Filings 03/12/2020
Aclarion, Inc. (ACON) - D/A SEC Filings 05/15/2018
Aclarion, Inc. (ACON) - D SEC Filings 08/11/2017
Aclarion, Inc. (ACON) - D SEC Filings 03/03/2015

Press Releases

StockPrice Release
Aclarion's nociscan solution to play key role in groundbreaking lifehab trial evaluating the diagnosis and treatment of chronic low back pain 04/25/2024
Aclarion announces closing of $3.0 million public offering 02/27/2024
Aclarion announces pricing of $3.0 million public offering 02/26/2024
Aclarion announces successful financings; plans to launch clarity trial and provides update on next steps of alphatec strategic partnership 02/05/2024
Aclarion expands nociscan access into phoenix with key opinion leader surgeon advisor juan uribe, md 01/22/2024
Aclarion announces reverse stock split 01/02/2024
Aclarion announces key commercial milestone with completion of 1,000 nociscan exams 11/27/2023
Aclarion expands immediate nociscan access into new york city with tenth key opinion leader surgeon advisor addition roger hartl, md 11/06/2023
Aclarion announces signing of commercial agreement with porter hospital, an adventhealth facility, to bring nociscan technology to denver 10/25/2023
Aclarion announces nociscan® cost-effectiveness poster presented at 45th annual smdm meeting 10/24/2023
Aclarion announces signing strategic partnership letter of intent with atec to advance commercialization of nociscan 10/23/2023
Aclarion, inc. announces filing of delayed 10-q quarterly report 08/25/2023
Aclarion announces new commercial engagement with the imaging center, grand rapids, mi 06/14/2023
Aclarion announces statistically significant nociscan® cost-effectiveness abstract presented at isass annual meeting 06/08/2023
Aclarion announces new engagement with the london clinic and london spine clinic 05/30/2023
Aclarion's key opinion leader program adds ninth surgeon advisor with addition of dean karahalios, md 05/23/2023
Aclarion, inc. announces delayed 10-q filing 05/23/2023
Aclarion announces non-convertible debt financing to achieve three critical catalysts 05/19/2023
Aclarion to host thought leadership symposium at spineweek 2023 04/28/2023
Aclarion announces alpesh patel md mba as a key opinion leader physician advisor 03/07/2023
Aclarion supports thought leadership at the 2nd annual sonntag spine symposium 02/15/2023
Aclarion to present at the jan 26th virtual investor summit microcap event 01/17/2023
Dr. christopher ames to join aclarion as a key opinion leader surgeon advisor 12/22/2022
Aclarion adds to strong patent portfolio with notice of allowance for new u.s. patent application addressing key pain indicator biomarker 12/01/2022
Dr. sigurd berven to join aclarion as a key opinion leader surgeon advisor 10/24/2022
Aclarion announces participation at the nass 37th annual meeting 10/10/2022
John keller m.d. to join aclarion as a key opinion leader surgeon advisor 10/03/2022
Nociscan selected for inclusion in pivotal national institutes of health (nih) study for low back pain 09/19/2022

Unlock

ACON Ratings Summary

ACON Quant Ranking